首页> 外文期刊>Biosensors & Bioelectronics: The International Journal for the Professional Involved with Research, Technology and Applications of Biosensers and Related Devices >A sensitive fluorescence anisotropy method for the direct detection of cancer cells in whole blood based on aptamer-conjugated near-infrared fluorescent nanoparticles
【24h】

A sensitive fluorescence anisotropy method for the direct detection of cancer cells in whole blood based on aptamer-conjugated near-infrared fluorescent nanoparticles

机译:基于适体偶联的近红外荧光纳米粒子的全血中癌细胞直接检测的灵敏荧光各向异性方法

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Based on the aptamer-conjugated core-shell near-infrared fluorescent nanoparticles (NIR-Nps) and fluorescence anisotropy measurement, the present study reported proof-of-principle for a rapid homogeneous assay approach that can detect target cancer cells without the need of the complicated separation steps in whole blood samples. Experimental investigation showed that the novel NIR-Nps have negligible background fluorescence and low inner filtration interference in complex biologic systems such as whole blood. The specific recognition characteristic of aptamer in whole blood samples was investigated by using the proposed fluorescence anisotropy method. The results showed that the fluorescent nanoparticle-tagged aptamer probes sequence could achieve specific recognition of the target cancer cells from complex mixtures including whole blood samples. And the reaction conditions for the binding between fluorescent nano particle-conjugated aptamer probes and target cancer cells were optimized. The present approach can exhibit sensitive and reproducible fluorescence anisotropy responses to the target cells concentration and the calibration curve showed good linearity when the target cells concentration is in the range from 4.0 x 10(3) to 7.0 x 1(0)5 cells/mL. Moreover, the present fluorescence anisotropy assay technique could be practically utilized for the detection of acute leukemia samples with improved capabilities and be comparable to the immunophenotyping methods clinically used.
机译:基于适体缀合的核壳近红外荧光纳米颗粒(NIR-Nps)和荧光各向异性测量,本研究报告了一种快速均质测定方法的原理证明,该方法可以检测目标癌细胞而无需全血样品中复杂的分离步骤。实验研究表明,新型NIR-Nps在复杂的生物系统(例如全血)中具有可忽略的背景荧光和较低的内部过滤干扰。利用提出的荧光各向异性方法研究了适体在全血样品中的特异性识别特性。结果表明,带有荧光纳米标签的适体探针序列可以从包括全血样品在内的复杂混合物中特异性识别靶癌细胞。并优化了荧光纳米粒子偶联的适体探针与靶癌细胞结合的反应条件。当目标细胞浓度在4.0 x 10(3)至7.0 x 1(0)5细胞/ mL范围内时,本方法可表现出对目标细胞浓度的敏感且可再现的荧光各向异性响应,并且校准曲线显示出良好的线性。而且,本发明的荧光各向异性测定技术可实际用于检测急性白血病样品,具有改进的能力,并且可与临床上使用的免疫表型方法相媲美。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号